Biopharming is the process of producing (or 'farming') medicinal compounds for therapeutic use using transgenic plants or animals. This entails putting target genes into hosts (crops or animals) that would not usually express them. The desired component may be expressed in a form that may be harvested on a regular basis (e.g., milk, eggs, fruits, etc.). The use of crops for bio-production of a recombinant protein (i.e., enzyme or antibody) or a system that includes bioreactors in vitro is referred to as biopharming. In comparison to industrial expenses, this approach provides great economic and health benefits, aided by new biotechnology methods that are improving. Plant biopharming is described as the cultivation of transgenic plants that have been genetically modified to produce "humanised" medicinal compounds for human use. "Molecular farming" is another term for biopharming. Corn, soybeans, rice, tobacco, and potatoes engineered to generate a material, usually a protein, vaccines, in their fruit, leaves, seeds, or tubers, are the most popular plants now being investigated for biopharming.
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Current advances, future directions, challenges, and opportunities in biotechnology
Auwalu Muttaka, Federal University Gusau, Nigeria
Title : Managing allelopathic weeds in wheat cultivars: Strategies for arid conditions in D.I. Khan, KP, Pakistan
Iqtidar Hussain, Gomal University, Pakistan
Title : Aluminium mediated expression of dehydration stress protein and ability of Al-acclimatized immobilized Nostoc muscorum: A strategy to combat abiotic stress and its potential as a biofertilizer
Alvina Farooqui, Integral University, India
Title : Bioleaching of metals from cellphones batteries by a co-fungus medium in presence of carbon materials
Khashayar Partovi, ISQI, Iran (Islamic Republic of)